Dayong Si

725 citations
22 papers · 571 indexed · h-index 12
Topics
Pharmacogenetics and Drug Metabolism (9 papers)Drug Transport and Resistance Mechanisms (7 papers)Inflammatory mediators and NSAID effects (5 papers)
Partner nations
ChinaJapanNew Zealand

In The Last Decade

Dayong Si

22 papers receiving 562 citations

Peers

Dayong Si
Comparison fields: 5 of 93
  • Pharmacology 310
  • Molecular Biology 176
  • Oncology 155
  • Pharmacology 147
  • Endocrinology, Diabetes and Metabolism 71
Replace Stephanie D. Turner with:
Stephanie D. Turner United States
Marc Bertrand France
Mika Kurkela Finland
Minxia M. He United States
Chitra Sridar United States
Bok-Ryang Kim South Korea
Aleksanteri Petsalo Finland
Yasushi Yoshigae Japan
Hiromitsu Nakasa Japan
Martine Bourrié France
Dayong Si relative to Stephanie D. Turner United States Stephanie D. Turner's profile →
Citations per field
00.5×1.5×1.8×
Stephanie D. Turner · 1×
Citations per year

Countries citing papers authored by Dayong Si

Since Specialization
Citations

This map shows the geographic impact of Dayong Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayong Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayong Si more than expected).

Fields of papers citing papers by Dayong Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayong Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayong Si. The network helps show where Dayong Si may publish in the future.

Co-authorship network of co-authors of Dayong Si

This figure shows the co-authorship network connecting the top 25 collaborators of Dayong Si. A scholar is included among the top collaborators of Dayong Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayong Si. Dayong Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 2
5 1
6 21
7 19
8 18
9 9
10 5
11 9
12 19
13 22
14 125
15 49
16 28
17 60
18 42
19 47
20 80

About Dayong Si

Dayong Si is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 22 papers that have together received 571 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Inflammatory mediators and NSAID effects (5 papers). The work is most often cited by research in Pharmacology (310 citations), Pharmacology (147 citations) and Biochemistry (60 citations). Dayong Si has collaborated with scholars based in China, Japan and New Zealand. Frequent co-authors include Hui Zhou, Yingjie Guo, Dafang Zhong, Xiaoyan Chen, J. Paul Fawcett, Juan Wang, Ying Wang, Yingjie Guo, Ze‐Sheng Li and Dafang Zhong. Their work appears in journals such as Applied and Environmental Microbiology, Applied Microbiology and Biotechnology and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026